|
DCTN5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.31530009106484E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.46729994610473E-09 |
| Normal-vs-Stage2 |
3.337100E-03 |
| Normal-vs-Stage3 |
1.56600288292452E-11 |
| Normal-vs-Stage4 |
1.77550196767129E-11 |
| Stage1-vs-Stage2 |
1.372420E-01 |
| Stage1-vs-Stage3 |
3.359900E-02 |
| Stage1-vs-Stage4 |
7.020300E-03 |
| Stage2-vs-Stage3 |
4.080900E-03 |
| Stage2-vs-Stage4 |
8.012900E-04 |
| Stage3-vs-Stage4 |
2.024400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.18359988476868E-10 |
| Normal-vs-AfricanAmerican |
1.80019000000087E-05 |
| Normal-vs-Asian |
1.6576000000379E-06 |
| Caucasian-vs-AfricanAmerican |
9.096200E-01 |
| Caucasian-vs-Asian |
7.775600E-01 |
| AfricanAmerican-vs-Asian |
8.998800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0206999689899E-09 |
| Normal-vs-Female |
1.00219998966367E-09 |
| Male-vs-Female |
1.274840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.10730000408333E-08 |
| Normal-vs-Age(41-60Yrs) |
1.15569998015985E-10 |
| Normal-vs-Age(61-80Yrs) |
6.80580000134157E-08 |
| Normal-vs-Age(81-100Yrs) |
1.160690E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.444000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.885600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.446400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.999800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.764600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.458200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.022300E-02 |
| Classical-VS-Follicular |
2.293800E-01 |
| Classical-VS-Other |
5.545900E-02 |
| Classical-VS-Normal |
7.9437001421212E-10 |
| Tall-VS-Follicular |
1.269520E-02 |
| Tall-VS-Other |
3.756800E-01 |
| Tall-VS-Normal |
4.63799998406955E-09 |
| Follicular-VS-Other |
7.314100E-02 |
| Follicular-VS-Normal |
1.371670E-04 |
| Other-VS-Normal |
1.64806999999323E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67110000176751E-08 |
| Normal-vs-N1 |
6.90419943438769E-11 |
| N0-vs-N1 |
2.620200E-03 |
|
|
